Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Provided By GlobeNewswire
Last update: Jan 8, 2025
SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET).
Read more at globenewswire.com
